Evidence map›Paper›PMID 27933927›Full record

ArticleJournal of the American Chemical Society2016

Three-Dimensionally Functionalized Reverse Phase Glycoprotein Array for Cancer Biomarker Discovery and Validation.

Li Pan, Hillary Andaluz Aguilar, Linna Wang, Anton Iliuk, W Andy Tao

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Mapping the low abundant plasma glycoproteome using Ranachrome-5 immobilized magnetic terpolymer as improved HILIC sorbent.Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2023
    Article
  5. Review
  6. Profiling Glycoproteins on Functionalized Reverse Phase Protein Array.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Li Pan
Hillary Andaluz Aguilar
Linna Wang
Anton IliukTymora Analytical Operations , West Lafayette, Indiana 47906, United States.
W Andy TaoTymora Analytical Operations , West Lafayette, Indiana 47906, United States.
Center for Cancer Research · USTymora Analytical Operations (United States) · US

Funding

Transgenic Mouse Core Facility Shared Resource (TMCF-SR)P30CA023168 · NCI · PURDUE UNIVERSITY WEST LAFAYETTE · PI Andrea L Kasinski · 1985 to 2026
$43.4M
A Proteomic Platform to identify and Validate Biomarkers in Metabolic Syndrome and Coronary Artery DiseaseR01GM111788 · NIGMS · PURDUE UNIVERSITY · PI TAO, W. ANDY · 2015 to 2017
$900k
Metal ion-functionalized soluble nanopolymers: A new analytical platform for plasR41GM109626 · NIGMS · TYMORA ANALYTICAL OPERATIONS, LLC · PI TAO, W. ANDY · 2014 to 2015
$641k
Developing novel RPPA for the detection of metastatic prostate cancerR41CA210772 · NCI · TYMORA ANALYTICAL OPERATIONS, LLC · PI TAO, W. ANDY · 2016 to 2018
$227k
NCI NIH HHS P30 CA023168NCI NIH HHS R41 CA210772NIGMS NIH HHS R01 GM111788NIGMS NIH HHS R41 GM109626
6 · The paper itself

Abstract

Glycoproteins have vast structural diversity that plays an important role in many biological processes and have great potential as disease biomarkers. Here, we report a novel functionalized reverse phase protein array (RPPA), termed polymer-based reverse phase glycoprotein array (polyGPA), to capture and profile glycoproteomes specifically, and validate glycoproteins. Nitrocellulose membrane functionalized with globular hydroxyaminodendrimers was used to covalently capture preoxidized glycans on glycoproteins from complex protein samples such as biofluids. The captured glycoproteins were subsequently detected using the same validated antibodies as in RPPA. We demonstrated the outstanding specificity, sensitivity, and quantitative capabilities of polyGPA by capturing and detecting purified as well as endogenous α-1-acid glycoprotein (AGP) in human plasma. We further applied quantitative N-glycoproteomics and the strategy to validate a panel of glycoproteins identified as potential biomarkers for bladder cancer by analyzing urine glycoproteins from bladder cancer patients or matched healthy individuals.

Indexed as

Biomarkers, TumorGlycoproteinsHumansProtein Array AnalysisUrinary Bladder NeoplasmsBiomarkers, TumorGlycoproteins

Identifiers

PMID27933927
PMCPMC5310384
OpenAlexW2550554589

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.